Применение аутологичной обогащенной тромбоцитами плазмы в репродуктивной медицине

Авторы

  • С.М. Магарманова
  • Т.Д. Укбаева

DOI:

https://doi.org/10.37800/RM2021-1-8

Ключевые слова:

обогащенная тромбоцитами плазма, PRP-терапия, репродуктология, регенерация эндометрия, экстракорпоральное оплодотворение

Аннотация

Обогащенная тромбоцитами плазма (ОТП, PRP) – это биологический продукт, определяемый как часть плазменной фракции крови, с концентрацией тромбоцитов, превышающей нормальное физиологическое значение. ОТП широко применяется в ортопедии и спортивной медицине для устранения болевых симптомов за счет стимуляции процессов естественного заживления. В последние годы появились публикации, которые демонстрируют перспективы применения ОТП в протоколах вспомогательных репродуктивных технологий. В данной статье представлен обзор и систематизация информации о механизме действия биологически активных компонентов ОТП, классификации препаратов и клиническом применении в области репродуктивной медицины.

Библиографические ссылки

Manini D. R., Shega F. D., Guo C., Wang Y. (2020) Role of Platelet-Rich Plasma in Spinal Fusion Surgery: Systematic Review and Meta-Analysis, Advances in orthopedics.- P.798-816.

Everts P., Onishi K., Jayaram P., Lana J. F., Mautner K. (2020) Platelet-Rich Plasma: New Performance Understandings and Therapeutic Considerations in 2020, International journal of molecular sciences. 21(20). P.779-794.

Sulaeva O.N. (2017) Poluchenie bogatoj trombocitami plazmy: mify i real'nost'.[Preparation of platelet-rich plasma: myths and reality] Svet mediciny i biologii.[The light of medicine and biology] 3 (61). P.3-6.

Aghajanova L., Houshdaran S., Balayan S. (2018) In vitro evidence that platelet-rich plasma stimulates cellular processes involved in endometrial regeneration.Journal of assisted reproduction and genetics.35(5). P.757–770.

Dejkalo V. P., Mastykov A. N., Boloboshko K. B. (2011) Obogashchennaya trombocitami plazma v lechenii zabolevanij i povrezhdenij oporno-dvigatel'nogo apparata[Platelet-rich plasma in the treatment of diseases and injuries of the musculoskeletal system]. Vestnik VGMU[Herald VSMU]. vol 4. P.6-11.

Mariani E., Pulsatelli L.(2020) Platelet Concentrates in Musculoskeletal Medicine. International journal of molecular sciences. - 21(4). - P.132-148.

Dawood, A. S., Salem, H. A. (2018). Current clinical applications of platelet-rich plasma in various gynecological disorders: An appraisal of theory and practice. Clinical and experimental reproductive medicine, 45(2), P. 67–74.

Xu, J., Gou, L., Zhang, P., Li, H., Qiu, S. (2020). Platelet-rich plasma and regenerative dentistry. Australian dental journal, 65(2), P.131–142.

Dohan Ehrenfest, D. M., Andia, I., Zumstein, M. A., Zhang, C. Q., Pinto, N. R., Bielecki, T. (2014). Classification of platelet concentrates (Platelet-Rich Plasma-PRP, Platelet-Rich Fibrin-PRF) for topical and infiltrative use in orthopedic and sports medicine: current consensus, clinical implications and perspectives. Muscles, ligaments and tendons journal, 4(1), P. 3–9.

Dohan Ehrenfest, D. M., Bielecki, T., Mishra, A., Borzini, P., Inchingolo, F., Sammartino, G., Rasmusson, L., Everts, P.A. (2012). In search of a consensus terminology in the field of platelet concentrates for surgical use: platelet-rich plasma (PRP), platelet-rich fibrin (PRF), fibrin gel polymerization and leukocytes. Current pharmaceutical biotechnology, 13(7), P.1131–1137.

Mishra A., Harmon K., Woodall J., Vieira, A. (2012) Sports medicine applications of platelet rich plasma. Current pharmaceutical biotechnology. 13(7). P.1185–1195.

Magalon J., Chateau A. L., Bertrand B., Louis M. L., Silvestre A., Giraudo L., Veran J., Sabatier F.(2016) DEPA classification: a proposal for standardising PRP use and a retrospective application of available devices.BMJ open sport & exercise medicine. 2(1).-P.1-5.

Blair P., Flaumenhaft R. (2009) Platelet alpha-granules: basic biology and clinical correlates.//Blood reviews. 23(4). P.177–189.

Michelson A., Cattaneo M., Frelinger A., Newman P. (2019) Platelets. Cambridge:Academic Press.- 2019.-4th edition.-PP.235-248, 745-789.

Everts P. A., Knape J. T., Weibrich G., Schönberger J. P., Hoffmann J., Overdevest E. P., Box H. A., van Zundert A.(2006) Platelet-rich plasma and platelet gel: a review. The journal of extra-corporeal technology. 38(2).- P.174–187.

Brown R. L., Breeden M. P., Greenhalgh, D. G.(1994) PDGF and TGF-alpha act synergistically to improve wound healing in the genetically diabetic mouse.The Journal of surgical research. 56(6).- P.562–570.

Haunschild E. D., Huddleston H. P., Chahla J., Gilat R., Cole B. J., Yanke, A. B. (2020) Platelet-Rich Plasma Augmentation in Meniscal Repair Surgery: A Systematic Review of Comparative Studies. Arthroscopy : the journal of arthroscopic & related surgery. 36(6), P.1765–1774.

Pantos K., Nitsos N., Kokkali G., Vaxevanoglou T., Markomichali C., Pantou A. (2016) Ovarian rejuvenation and folliculogenesis reactivation in peri-menopausal women after autologous plateletrich plasma treatment. [Internet sources] URL: https://sa1s3.patientpop.com/assets/docs/111052.pdf (Accessed: 08.12.2020). The 32nd Annual Meeting of ESHRE; 2016 July 3-6; Helsinki, Finland.

Sills E. S., Rickers N. S., Li X.,Palermo G. D.(2018) First data on in vitro fertilization and blastocyst formation after intraovarian injection of calcium gluconate-activated autologous platelet rich plasma. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology. 34(9). - P.756–760.

Cakiroglu Y., Saltik A., Yuceturk, A, Karaosmanoglu O., Kopuk S. Y., Scott R. T., Tiras B., Seli E. (2020) Effects of intraovarian injection of autologous platelet rich plasma on ovarian reserve and IVF outcome parameters in women with primary ovarian insufficiency. Aging. 12(11). [Internet sources]URL: https://www.ncbi.nlm.nih.gov/pmc/articles/ PMC7346073/ (Accessed 11.12.2020)

Farimani M., Heshmati S., Poorolajal J., Bahmanzadeh M. (2019) A report on three live births in women with poor ovarian response following intra-ovarian injection of platelet-rich plasma (PRP). Molecular biology reports. 46(2). P. 1611–1616.

Kuznecova I.V., Zemlina N.S., Rashidov T.N., Kovalenko M.A. (2017)Problema tonkogo endometriya i vozmozhnye puti ee resheniya. [The problem of the thin endometrium and possible solutions]. Akusherstvo i ginekologiya [Obstetrics and gynecology]. 1 (5).-P. 42-49.

Aghajanova L., Houshdaran S., Balayan S., Manvelyan E., Irwin JC., Huddleston HG., Giudice LC.(2018) In vitro evidence that platelet-rich plasma stimulates cellular processes involved in endometrial regeneration. Journal of assisted reproduction and genetics.35(5).-P.757-770.

Javaheri A., Kianfar K., Pourmasumi S., Eftekhar M.(2020) Platelet-rich plasma in the management of Asherman's syndrome: An RCT. International journal of reproductive biomedicine. 18(2).-P.113–120.

Wang X., Liu L., Mou S., Zhao H., Fang J., Xiang Y., Zhao T., Sha T., Ding J., Hao C.(2018) Investigation of plateletrich plasma in increasing proliferation and migration of endometrial mesenchymal stem cells and improving pregnancy outcome of patients with thin endometrium. Journal of cellular biochemistry. doi.org/10.1002/jcb.28014[Internet sources]. URL: https://pubmed.ncbi.nlm.nih.gov/30506864/ (Accessed 11.12.2021).

Jang H. Y., Myoung S. M., Choe J. M., Kim T., Cheon Y. P., Kim Y. M., Park, H. (2017) Effects of Autologous Platelet Rich Plasma on Regeneration of Damaged Endometrium in Female Rats. Yonsei medical journal. 58(6).- P.1195–1203.

Nazari L., Salehpour S., Hoseini S., Zadehmodarres S., Ajori L.(2016) Effects of autologous platelet-rich plasma on implantation and pregnancy in repeated implantation failure: A pilot study. International journal of reproductive biomedicine. 14(10).- P. 625–628.

Obidnyak D.M., Gzgzyan A.M, Niauri D.A., CHkhaidze I.Z. (2017) Perspektivy primeneniya autologichnoj obogashchennoj trombocitami plazmy krovi u pacientok s povtornymi neeffektivnymi popytkami implantacii [Prospects for the use of autologous platelet-rich blood plasma in patients with repeated ineffective implantation attempts.]. Problemy reprodukcii [Reproduction problems]. vol 23(5). P.84-88.

Chang Y., Li J., Chen Y., Wei L., Yang X., Shi Y., Liang X. (2015) Autologous platelet-rich plasma promotes endometrial growth and improves pregnancy outcome during in vitro fertilization. International journal of clinical and experimental medicine. vol 8(1).- P.1286–1290.

Mustafin R.T., Magarmanova S.M., Gerdt T.M., Kaldygulova G.B.(2019) Primenenie autologichnoj obogashchennoj trombocitami plazmy (aPRP) dlya podgotovki endometriya v ciklah VRT [Application of autologous platelet-rich plasma (aPRP) for preparation of the endometrium in ART cycles]. Reproduktivnaya medicina [Reproductive medicine]. vol. 3(40). - P.37-39.

Tehraninejad E.S., Kashani N.G., Hosseini A., Tarafdari A.(2020) Autologous platelet-rich plasma infusion does not

improve pregnancy outcomes in frozen embryo transfer cycles in women with history of repeated implantation failure without thin endometrium. The Journal of Obstetrics and Gynaecology Research. vol.47(1).-P.147-151.[Internet sources]. URL: https://europepmc.org/article/med/32840031 (Accessed 15.12.20).

Дополнительные файлы

Опубликован

01.04.2021

Как цитировать

[1]
Магарманова, С. и Укбаева, Т. 2021. Применение аутологичной обогащенной тромбоцитами плазмы в репродуктивной медицине. Репродуктивная медицина. 1 (46) (апр. 2021), 36–41. DOI:https://doi.org/10.37800/RM2021-1-8.